Langerin Activators
Langerin activators encompass a diverse array of chemicals that modulate the activity of Langerin, a C-type lectin receptor expressed predominantly in dendritic cells. These activators exert their effects through various signaling pathways, ultimately influencing Langerin expression and function. Retinoic acid and its isomer, 9-cis-retinoic acid, are notable Langerin activators that act through the retinoic acid signaling pathway. By directly binding to retinoic acid receptors, these compounds enhance the transcriptional activity of Langerin, leading to increased expression. This mechanism underscores the importance of retinoic acid receptors in regulating Langerin levels within cells. Thapsigargin indirectly activates Langerin by modulating calcium signaling. Inhibition of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump by thapsigargin results in elevated cytosolic calcium levels, influencing downstream pathways that impact Langerin expression. Similarly, SB431542, a selective inhibitor of TGF-β type I receptors, activates Langerin by affecting the TGF-β signaling pathway.
Forskolin, a cAMP-PKA pathway modulator, indirectly activates Langerin by stimulating adenylate cyclase and elevating cAMP levels. The resulting activation of protein kinase A (PKA) may influence Langerin expression through downstream signaling events. Calcitriol, the active form of vitamin D, activates Langerin by interacting with vitamin D receptors, promoting their transcriptional activity. Sodium butyrate, a histone deacetylase (HDAC) inhibitor, influences Langerin through histone acetylation, facilitating transcriptional activation. Bisindolylmaleimide I indirectly activates Langerin by inhibiting protein kinase C (PKC), while U-73122 modulates phospholipase C (PLC) signaling to impact Langerin expression. Sodium orthovanadate, a protein tyrosine phosphatase (PTP) inhibitor, activates Langerin by enhancing tyrosine phosphorylation signaling. In summary, Langerin activators present a nuanced landscape, exploiting diverse cellular pathways to enhance the expression and function of this crucial C-type lectin receptor. Understanding the molecular mechanisms underlying these activations opens avenues for exploring Langerin's role in immune responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Activates Langerin by influencing the retinoic acid signaling pathway. Retinoic acid acts as a ligand for retinoic acid receptors, leading to increased Langerin expression. This compound can directly bind to retinoic acid receptors, promoting their transcriptional activity and subsequently enhancing Langerin levels in cells. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Indirectly activates Langerin through modulation of calcium signaling. Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump, leading to elevated cytosolic calcium levels. The increased calcium concentration can activate signaling pathways that influence Langerin expression, indirectly enhancing its activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Indirectly activates Langerin through the cAMP-PKA pathway. Forskolin stimulates adenylate cyclase, leading to increased cAMP levels. Elevated cAMP can activate protein kinase A (PKA), which may influence Langerin expression through downstream signaling events. This indirect activation links forskolin to the modulation of cellular pathways that impact Langerin activity. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
Activates Langerin by influencing the vitamin D signaling pathway. Calcitriol, the active form of vitamin D, binds to vitamin D receptors, leading to increased Langerin expression. This compound directly interacts with vitamin D receptors, promoting their transcriptional activity and subsequently enhancing Langerin levels in cells. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Indirectly activates Langerin through modulation of protein kinase C (PKC) signaling. Bisindolylmaleimide I is a selective inhibitor of PKC, and its inhibition may lead to increased Langerin expression. By blocking PKC activity, this compound influences downstream signaling pathways that impact Langerin, providing an indirect mechanism for its activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Activates Langerin through histone acetylation. Sodium butyrate is a histone deacetylase (HDAC) inhibitor, leading to increased Langerin expression. By inhibiting HDAC, sodium butyrate promotes histone acetylation, potentially facilitating transcriptional activation of Langerin and enhancing its levels in cells. | ||||||
9-cis-Retinoic acid | 5300-03-8 | sc-205589 sc-205589B sc-205589C sc-205589D sc-205589A | 1 mg 25 mg 250 mg 500 mg 5 mg | $71.00 $424.00 $3121.00 $5722.00 $148.00 | 10 | |
Activates Langerin by influencing the retinoic acid signaling pathway. 9-cis-retinoic acid, an isomer of all-trans-retinoic acid, acts as a ligand for retinoic acid receptors, leading to increased Langerin expression. This compound directly binds to retinoic acid receptors, promoting their transcriptional activity and subsequently enhancing Langerin levels in cells. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Activates Langerin by influencing tyrosine phosphorylation signaling. Sodium orthovanadate is a protein tyrosine phosphatase (PTP) inhibitor, leading to increased Langerin expression. By inhibiting PTP, this compound enhances tyrosine phosphorylation signaling, potentially facilitating transcriptional activation of Langerin and enhancing its levels in cells. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Indirectly activates Langerin through protein kinase C (PKC) activation. PMA is a PKC activator, leading to increased Langerin expression. By activating PKC, PMA influences downstream signaling pathways that impact Langerin, providing an indirect mechanism for its activation. | ||||||